Real-world testing practices, treatment patterns, and outcomes of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor-mutated advanced/metastatic non-small cell lung cancer: An international study.
- DOI
- 10.1016/j.ctarc.2026.101282
- Published
- 2026
- Container
- Cancer treatment and research communications
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ctarc.2026.101282,
title = {Real-world testing practices, treatment patterns, and outcomes of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor-mutated advanced/metastatic non-small cell lung cancer: An international study.},
author = {Samol J and Demedts I and Erman M and Kozlov V and Minatta JN and Moiseenko F and Mark M and Rajappa S and Bailey T and Wallis H and Servidio L and Kahangire DA and Zukin M},
year = {2026},
journal = {Cancer treatment and research communications},
doi = {10.1016/j.ctarc.2026.101282},
url = {https://doi.org/10.1016/j.ctarc.2026.101282}
}RIS
TY - JOUR TI - Real-world testing practices, treatment patterns, and outcomes of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor-mutated advanced/metastatic non-small cell lung cancer: An international study. AU - Samol J AU - Demedts I AU - Erman M AU - Kozlov V AU - Minatta JN AU - Moiseenko F AU - Mark M AU - Rajappa S AU - Bailey T AU - Wallis H AU - Servidio L AU - Kahangire DA AU - Zukin M PY - 2026 JO - Cancer treatment and research communications DO - 10.1016/j.ctarc.2026.101282 UR - https://doi.org/10.1016/j.ctarc.2026.101282 ER -
APA
J, S., I, D., M, E., V, K., JN, M., F, M., M, M., S, R., T, B., H, W., L, S., DA, K., & M, Z. (2026). Real-world testing practices, treatment patterns, and outcomes of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor-mutated advanced/metastatic non-small cell lung cancer: An international study.. Cancer treatment and research communications. https://doi.org/10.1016/j.ctarc.2026.101282
Source records
- pubmed · retrieved 2026-09-26T07:39:20.846Z